Skip to main content
Erschienen in: International Ophthalmology 4/2019

09.03.2018 | Original Paper

Vitreous IL-8 and VEGF levels in diabetic macular edema with or without subretinal fluid

verfasst von: Fatih Yenihayat, Berna Özkan, Murat Kasap, V. Levent Karabaş, Nil Güzel, Gürler Akpınar, Dilara Pirhan

Erschienen in: International Ophthalmology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the cytokine levels in vitreous samples of diabetic macular edema (DME) patients in comparison with nondiabetic patients, and to evaluate the effect of subretinal fluid on the cytokine levels of vitreous samples.

Methods

In this prospective case–control study, 11 eyes of 11 patients with DME and subretinal fluid, 11 eyes of 11 patients with DME without subretinal fluid, and 14 eyes of 14 patients who had undergone vitreoretinal surgery for the epiretinal membrane or a macular hole (control group) were evaluated. The blood glycated hemoglobin (HbA1c) level, vitreous vascular endothelial growth factor (VEGF), and interleukin-8 (IL-8) levels were determined.

Results

The vitreous VEGF level of patients in DME groups was significantly higher than the control group (p < 0.001) without significant difference between DME patients with and without subretinal fluid (p = 0.796). The vitreous IL-8 level of DME patients with subretinal fluid was significantly higher than both control (p = 0.002) and DME without subretinal fluid groups (p = 0.019). The blood HbA1c level was significantly higher in DME group with subretinal fluid than those without subretinal fluid (8.7 ± 1.32 and 7.1 ± 1.13%, respectively, p = 0.010). The only significant correlation was between vitreous VEGF level and blood HbA1c level in DME patients without subretinal fluid (r = 0.813, p = 0.002).

Conclusions

IL-8 level in vitreous samples was higher in DME patients with subretinal fluid than those without subretinal fluid, suggesting that inflammation is an important factor in the progression of DME leading to the subretinal fluid formation in diabetic patients.
Literatur
1.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy IV: diabetic macular edema. Ophthalmology 91:1464–1474CrossRefPubMed Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy IV: diabetic macular edema. Ophthalmology 91:1464–1474CrossRefPubMed
2.
Zurück zum Zitat Antcliff RJ, Marshall J (1999) The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 14:223–232CrossRefPubMed Antcliff RJ, Marshall J (1999) The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 14:223–232CrossRefPubMed
3.
8.
Zurück zum Zitat Otani T, Kishi S, Maruyama Y (1999) Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127:688–693CrossRef Otani T, Kishi S, Maruyama Y (1999) Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127:688–693CrossRef
9.
Zurück zum Zitat Özdemir H, Karaçorlu M, Karaçorlu SA (2005) Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. Am J Ophthalmol 140:251–255CrossRefPubMed Özdemir H, Karaçorlu M, Karaçorlu SA (2005) Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. Am J Ophthalmol 140:251–255CrossRefPubMed
12.
Zurück zum Zitat Gaucher D, Sebah C, Erginay A et al (2008) Optical Coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol 145:289–296CrossRefPubMed Gaucher D, Sebah C, Erginay A et al (2008) Optical Coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol 145:289–296CrossRefPubMed
13.
Zurück zum Zitat Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47:1953–1959CrossRefPubMed Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47:1953–1959CrossRefPubMed
14.
Zurück zum Zitat Marmor MF (1999) Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol 97:239–249CrossRefPubMed Marmor MF (1999) Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol 97:239–249CrossRefPubMed
15.
Zurück zum Zitat Kang SW, Park CY, Ham DI (2004) The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 137:313–322CrossRefPubMed Kang SW, Park CY, Ham DI (2004) The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 137:313–322CrossRefPubMed
16.
Zurück zum Zitat Nishikiori N, Osanai M, Chiba H et al (2007) Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy. Diabetes 56:1333–1340CrossRefPubMed Nishikiori N, Osanai M, Chiba H et al (2007) Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy. Diabetes 56:1333–1340CrossRefPubMed
17.
Zurück zum Zitat Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487CrossRefPubMed Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487CrossRefPubMed
18.
Zurück zum Zitat Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H (1995) Vascular endothelial factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 27:48–52CrossRefPubMed Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H (1995) Vascular endothelial factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 27:48–52CrossRefPubMed
19.
Zurück zum Zitat Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K (1996) The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinal retinas. Lab Invest 74:819–825PubMed Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K (1996) The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinal retinas. Lab Invest 74:819–825PubMed
20.
Zurück zum Zitat Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW (1999) Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occludens 1. J Biol Chem 274:23463–23467CrossRefPubMed Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW (1999) Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occludens 1. J Biol Chem 274:23463–23467CrossRefPubMed
21.
Zurück zum Zitat Kaji Y, Usui T, Ishida S et al (2007) Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci 48:858–865CrossRefPubMed Kaji Y, Usui T, Ishida S et al (2007) Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci 48:858–865CrossRefPubMed
22.
Zurück zum Zitat Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736–741CrossRef Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736–741CrossRef
23.
Zurück zum Zitat Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H (1997) Growth factor alterations in advanced diabetic retinopathy: a possible role of blood-retina barrier breakdown. Diabetes 46(Suppl 2):S26–S30CrossRefPubMed Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H (1997) Growth factor alterations in advanced diabetic retinopathy: a possible role of blood-retina barrier breakdown. Diabetes 46(Suppl 2):S26–S30CrossRefPubMed
24.
Zurück zum Zitat Ozdemir H, Karacorlu M, Karacorlu SA (2005) Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. Am J Ophthalmol 140:251–255CrossRefPubMed Ozdemir H, Karacorlu M, Karacorlu SA (2005) Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. Am J Ophthalmol 140:251–255CrossRefPubMed
26.
Zurück zum Zitat Aksunger A, Or M, Okur H, Hasanreisoğlu B, Akbatur H (1997) Role of interleukin 8 in the pathogenesis of proliferative vitreoretinopathy. Ophthalmologica 211:223–225CrossRefPubMed Aksunger A, Or M, Okur H, Hasanreisoğlu B, Akbatur H (1997) Role of interleukin 8 in the pathogenesis of proliferative vitreoretinopathy. Ophthalmologica 211:223–225CrossRefPubMed
27.
Zurück zum Zitat Petrovič MG, Korošec P, Košnik M, Hawlina M (2007) Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy. Am J Ophthalmol 143:175–176CrossRefPubMed Petrovič MG, Korošec P, Košnik M, Hawlina M (2007) Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy. Am J Ophthalmol 143:175–176CrossRefPubMed
30.
Zurück zum Zitat Klein R, Klein BE, Boss SE, Cruickshanks KJ (1995) Wisconsin-epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 102:7–16CrossRefPubMed Klein R, Klein BE, Boss SE, Cruickshanks KJ (1995) Wisconsin-epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 102:7–16CrossRefPubMed
Metadaten
Titel
Vitreous IL-8 and VEGF levels in diabetic macular edema with or without subretinal fluid
verfasst von
Fatih Yenihayat
Berna Özkan
Murat Kasap
V. Levent Karabaş
Nil Güzel
Gürler Akpınar
Dilara Pirhan
Publikationsdatum
09.03.2018
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 4/2019
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-018-0874-6

Weitere Artikel der Ausgabe 4/2019

International Ophthalmology 4/2019 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.